Canada · Health Canada Drug Product Database
FLUZONE QUADRIVALENT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 91717
- DIN
- 02432730
- Form
- Suspension
- Company as listed by source
- SANOFI VACCINES CANADA LTD.
- Source status
- Dormant (2026-03-13)
- Source last updated
- 2026-08-25
Source-listed ingredients
- HAEMAGGLUTININ-STRAIN A (H1N1) — 30 MCG — per 1 ML
- HAEMAGGLUTININ-STRAIN A (H3N2) — 30 MCG — per 1 ML
- HAEMAGGLUTININ-STRAIN B (VICTORIA) — 30 MCG — per 1 ML
- HAEMAGGLUTININ-STRAIN B (YAMAGATA) — 30 MCG — per 1 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 5ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →